Trademark (Mulpleta 01)
Mulpleta Tablet, Film Coated
Product Images NDC 59630-551
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Mulpleta (NDC 59630-551). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Shionogi Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Mulpleta 02)
Principal Display Panel (3 mg Tablet Blister Card Carton)
Mulpleta (lusutrombopag) tablets are for oral use only and available by prescription only. Each blister card contains 7 tablets, each with 3mg of lusutrombopag. The tablets are taken once a day for 7 days, and the Prescribing Information should be consulted for more information. The tablets should be stored at controlled room temperature and kept out of reach of children. The blister card can be opened using the instructions provided, and after taking a tablet, should be pushed back into the box until it locks into place. For more information about Mulpleta (lusutrombopag) tablets, visit www.mulpleta.com.*
Mulpleta 04
This is a pharmaceutical product called Mulpleta, containing 3 mg of lusutrombopag per tablet. It is for oral use only, and is RX only physician sample. It is not for sale and should be kept out of reach of children. The package contains opening instructions to follow while holding down a button. The provided information includes the NDC number, barcode, dosage information, and a website for further information on Mulpleta.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
